The global Treatment and Prevention of Herpes Labialis market size is expected to reach US$ 1592.7 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029.

Treatment and Prevention of Herpes Labialis - Market

The market is mainly driven by the significant applications of Treatment and Prevention of Herpes Labialis in various end use industries. The expanding demands from the External Use, Oral and Injection,, are propelling Treatment and Prevention of Herpes Labialis market. Valacyclovir, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Aciclovir segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Treatment and Prevention of Herpes Labialis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Treatment and Prevention of Herpes Labialis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Treatment and Prevention of Herpes Labialis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Treatment and Prevention of Herpes Labialis sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Treatment and Prevention of Herpes Labialis covered in this report include GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon and Luoxin, etc.

The global Treatment and Prevention of Herpes Labialis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

GSK

Novartis

Teva

Mylan

Cadila

Apotex

Daewoong Pharmaceutical

Livzon

Luoxin

Med shine

Bayer(Campho Phenique)

Blistex

Kelun Group

Hikma

Haiwang

Carmex

Cipher

Scope of Treatment and Prevention of Herpes Labialis - Market Report

Report Metric	Details
Report Name	Treatment and Prevention of Herpes Labialis - Market
Forecasted market size in 2029	US$ 1592.7 million
CAGR	4.2%
Forecasted years	2023 - 2029
Global Treatment and Prevention of Herpes Labialis market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.) Global Treatment and Prevention of Herpes Labialis market, Segment by Type: Valacyclovir Aciclovir Famciclovir Docosanol Other
Global Treatment and Prevention of Herpes Labialis market, by Application	External Use Oral Injection
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Treatment and Prevention of Herpes Labialis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Treatment and Prevention of Herpes Labialis - Market size in 2029?

Ans: The Treatment and Prevention of Herpes Labialis - Market size in 2029 will be US$ 1592.7 million.

What are the Application segmentation covered in the Treatment and Prevention of Herpes Labialis - Market report?

Ans: The Applications covered in the Treatment and Prevention of Herpes Labialis - Market report are External Use, Oral, Injection

1 Market Overview of Treatment and Prevention of Herpes Labialis

1.1 Treatment and Prevention of Herpes Labialis Market Overview

1.1.1 Treatment and Prevention of Herpes Labialis Product Scope

1.1.2 Treatment and Prevention of Herpes Labialis Market Status and Outlook

1.2 Global Treatment and Prevention of Herpes Labialis Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Treatment and Prevention of Herpes Labialis Market Size by Region (2018-2029)

1.4 Global Treatment and Prevention of Herpes Labialis Historic Market Size by Region (2018-2023)

1.5 Global Treatment and Prevention of Herpes Labialis Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Treatment and Prevention of Herpes Labialis Market Size (2018-2029)

1.6.1 North America Treatment and Prevention of Herpes Labialis Market Size (2018-2029)

1.6.2 Europe Treatment and Prevention of Herpes Labialis Market Size (2018-2029)

1.6.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size (2018-2029)

1.6.4 Latin America Treatment and Prevention of Herpes Labialis Market Size (2018-2029)

1.6.5 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size (2018-2029)

2 Treatment and Prevention of Herpes Labialis Market by Type

2.1 Introduction

2.1.1 Valacyclovir

2.1.2 Aciclovir

2.1.3 Famciclovir

2.1.4 Docosanol

2.1.5 Other

2.2 Global Treatment and Prevention of Herpes Labialis Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Treatment and Prevention of Herpes Labialis Historic Market Size by Type (2018-2023)

2.2.2 Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Treatment and Prevention of Herpes Labialis Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Treatment and Prevention of Herpes Labialis Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Treatment and Prevention of Herpes Labialis Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue Breakdown by Type (2018-2029)

3 Treatment and Prevention of Herpes Labialis Market Overview by Application

3.1 Introduction

3.1.1 External Use

3.1.2 Oral

3.1.3 Injection

3.2 Global Treatment and Prevention of Herpes Labialis Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Treatment and Prevention of Herpes Labialis Historic Market Size by Application (2018-2023)

3.2.2 Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Treatment and Prevention of Herpes Labialis Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Treatment and Prevention of Herpes Labialis Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Treatment and Prevention of Herpes Labialis Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue Breakdown by Application (2018-2029)

4 Treatment and Prevention of Herpes Labialis Competition Analysis by Players

4.1 Global Treatment and Prevention of Herpes Labialis Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Treatment and Prevention of Herpes Labialis as of 2022)

4.3 Date of Key Players Enter into Treatment and Prevention of Herpes Labialis Market

4.4 Global Top Players Treatment and Prevention of Herpes Labialis Headquarters and Area Served

4.5 Key Players Treatment and Prevention of Herpes Labialis Product Solution and Service

4.6 Competitive Status

4.6.1 Treatment and Prevention of Herpes Labialis Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 GSK

5.1.1 GSK Profile

5.1.2 GSK Main Business

5.1.3 GSK Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.1.4 GSK Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.1.5 GSK Recent Developments

5.2 Novartis

5.2.1 Novartis Profile

5.2.2 Novartis Main Business

5.2.3 Novartis Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.2.4 Novartis Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.2.5 Novartis Recent Developments

5.3 Teva

5.3.1 Teva Profile

5.3.2 Teva Main Business

5.3.3 Teva Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.3.4 Teva Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.3.5 Mylan Recent Developments

5.4 Mylan

5.4.1 Mylan Profile

5.4.2 Mylan Main Business

5.4.3 Mylan Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.4.4 Mylan Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.4.5 Mylan Recent Developments

5.5 Cadila

5.5.1 Cadila Profile

5.5.2 Cadila Main Business

5.5.3 Cadila Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.5.4 Cadila Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.5.5 Cadila Recent Developments

5.6 Apotex

5.6.1 Apotex Profile

5.6.2 Apotex Main Business

5.6.3 Apotex Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.6.4 Apotex Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.6.5 Apotex Recent Developments

5.7 Daewoong Pharmaceutical

5.7.1 Daewoong Pharmaceutical Profile

5.7.2 Daewoong Pharmaceutical Main Business

5.7.3 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.7.4 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.7.5 Daewoong Pharmaceutical Recent Developments

5.8 Livzon

5.8.1 Livzon Profile

5.8.2 Livzon Main Business

5.8.3 Livzon Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.8.4 Livzon Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.8.5 Livzon Recent Developments

5.9 Luoxin

5.9.1 Luoxin Profile

5.9.2 Luoxin Main Business

5.9.3 Luoxin Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.9.4 Luoxin Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.9.5 Luoxin Recent Developments

5.10 Med shine

5.10.1 Med shine Profile

5.10.2 Med shine Main Business

5.10.3 Med shine Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.10.4 Med shine Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.10.5 Med shine Recent Developments

5.11 Bayer(Campho Phenique)

5.11.1 Bayer(Campho Phenique) Profile

5.11.2 Bayer(Campho Phenique) Main Business

5.11.3 Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.11.4 Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.11.5 Bayer(Campho Phenique) Recent Developments

5.12 Blistex

5.12.1 Blistex Profile

5.12.2 Blistex Main Business

5.12.3 Blistex Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.12.4 Blistex Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.12.5 Blistex Recent Developments

5.13 Kelun Group

5.13.1 Kelun Group Profile

5.13.2 Kelun Group Main Business

5.13.3 Kelun Group Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.13.4 Kelun Group Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.13.5 Kelun Group Recent Developments

5.14 Hikma

5.14.1 Hikma Profile

5.14.2 Hikma Main Business

5.14.3 Hikma Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.14.4 Hikma Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.14.5 Hikma Recent Developments

5.15 Haiwang

5.15.1 Haiwang Profile

5.15.2 Haiwang Main Business

5.15.3 Haiwang Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.15.4 Haiwang Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.15.5 Haiwang Recent Developments

5.16 Carmex

5.16.1 Carmex Profile

5.16.2 Carmex Main Business

5.16.3 Carmex Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.16.4 Carmex Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.16.5 Carmex Recent Developments

5.17 Cipher

5.17.1 Cipher Profile

5.17.2 Cipher Main Business

5.17.3 Cipher Treatment and Prevention of Herpes Labialis Products, Services and Solutions

5.17.4 Cipher Treatment and Prevention of Herpes Labialis Revenue (US$ Million) & (2018-2023)

5.17.5 Cipher Recent Developments

6 North America

6.1 North America Treatment and Prevention of Herpes Labialis Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Treatment and Prevention of Herpes Labialis Market Dynamics

11.1 Treatment and Prevention of Herpes Labialis Industry Trends

11.2 Treatment and Prevention of Herpes Labialis Market Drivers

11.3 Treatment and Prevention of Herpes Labialis Market Challenges

11.4 Treatment and Prevention of Herpes Labialis Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Daewoong Pharmaceutical

LIVZON

Luoxin

Med shine

Bayer (Campho Phenique)

List of Tables

Table 1. Global Market Treatment and Prevention of Herpes Labialis Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Treatment and Prevention of Herpes Labialis Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Treatment and Prevention of Herpes Labialis Market Size Share by Region (2018-2023)

Table 4. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Treatment and Prevention of Herpes Labialis Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Treatment and Prevention of Herpes Labialis Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2018-2023)

Table 9. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2024-2029)

Table 11. North America Treatment and Prevention of Herpes Labialis Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Treatment and Prevention of Herpes Labialis Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Treatment and Prevention of Herpes Labialis Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Treatment and Prevention of Herpes Labialis Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Treatment and Prevention of Herpes Labialis Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Treatment and Prevention of Herpes Labialis Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Treatment and Prevention of Herpes Labialis Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Treatment and Prevention of Herpes Labialis Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2018-2023)

Table 24. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2024-2029)

Table 26. North America Treatment and Prevention of Herpes Labialis Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Treatment and Prevention of Herpes Labialis Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Treatment and Prevention of Herpes Labialis Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Treatment and Prevention of Herpes Labialis Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Treatment and Prevention of Herpes Labialis Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Treatment and Prevention of Herpes Labialis Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Treatment and Prevention of Herpes Labialis Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Treatment and Prevention of Herpes Labialis as of 2022)

Table 39. Date of Key Players Enter into Treatment and Prevention of Herpes Labialis Market

Table 40. Global Treatment and Prevention of Herpes Labialis Key Players Headquarters and Area Served

Table 41. Treatment and Prevention of Herpes Labialis Product Solution and Service

Table 42. Global Treatment and Prevention of Herpes Labialis Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. GSK Basic Information List

Table 45. GSK Description and Business Overview

Table 46. GSK Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 47. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of GSK (2018-2023)

Table 48. GSK Recent Developments

Table 49. Novartis Basic Information List

Table 50. Novartis Description and Business Overview

Table 51. Novartis Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 52. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Novartis (2018-2023)

Table 53. Novartis Recent Developments

Table 54. Teva Basic Information List

Table 55. Teva Description and Business Overview

Table 56. Teva Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 57. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Teva (2018-2023)

Table 58. Teva Recent Developments

Table 59. Mylan Basic Information List

Table 60. Mylan Description and Business Overview

Table 61. Mylan Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 62. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Mylan (2018-2023)

Table 63. Mylan Recent Developments

Table 64. Cadila Basic Information List

Table 65. Cadila Description and Business Overview

Table 66. Cadila Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 67. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Cadila (2018-2023)

Table 68. Cadila Recent Developments

Table 69. Apotex Basic Information List

Table 70. Apotex Description and Business Overview

Table 71. Apotex Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 72. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Apotex (2018-2023)

Table 73. Apotex Recent Developments

Table 74. Daewoong Pharmaceutical Basic Information List

Table 75. Daewoong Pharmaceutical Description and Business Overview

Table 76. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 77. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Daewoong Pharmaceutical (2018-2023)

Table 78. Daewoong Pharmaceutical Recent Developments

Table 79. Livzon Basic Information List

Table 80. Livzon Description and Business Overview

Table 81. Livzon Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 82. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Livzon (2018-2023)

Table 83. Livzon Recent Developments

Table 84. Luoxin Basic Information List

Table 85. Luoxin Description and Business Overview

Table 86. Luoxin Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 87. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Luoxin (2018-2023)

Table 88. Luoxin Recent Developments

Table 89. Med shine Basic Information List

Table 90. Med shine Description and Business Overview

Table 91. Med shine Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 92. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Med shine (2018-2023)

Table 93. Med shine Recent Developments

Table 94. Bayer(Campho Phenique) Basic Information List

Table 95. Bayer(Campho Phenique) Description and Business Overview

Table 96. Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 97. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Bayer(Campho Phenique) (2018-2023)

Table 98. Bayer(Campho Phenique) Recent Developments

Table 99. Blistex Basic Information List

Table 100. Blistex Description and Business Overview

Table 101. Blistex Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 102. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Blistex (2018-2023)

Table 103. Blistex Recent Developments

Table 104. Kelun Group Basic Information List

Table 105. Kelun Group Description and Business Overview

Table 106. Kelun Group Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 107. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Kelun Group (2018-2023)

Table 108. Kelun Group Recent Developments

Table 109. Hikma Basic Information List

Table 110. Hikma Description and Business Overview

Table 111. Hikma Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 112. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Hikma (2018-2023)

Table 113. Hikma Recent Developments

Table 114. Haiwang Basic Information List

Table 115. Haiwang Description and Business Overview

Table 116. Haiwang Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 117. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Haiwang (2018-2023)

Table 118. Haiwang Recent Developments

Table 119. Carmex Basic Information List

Table 120. Carmex Description and Business Overview

Table 121. Carmex Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 122. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Carmex (2018-2023)

Table 123. Carmex Recent Developments

Table 124. Cipher Basic Information List

Table 125. Cipher Description and Business Overview

Table 126. Cipher Treatment and Prevention of Herpes Labialis Products, Services and Solutions

Table 127. Revenue (US$ Million) in Treatment and Prevention of Herpes Labialis Business of Cipher (2018-2023)

Table 128. Cipher Recent Developments

Table 129. North America Treatment and Prevention of Herpes Labialis Market Size by Country (2018-2023) & (US$ Million)

Table 130. North America Treatment and Prevention of Herpes Labialis Market Size by Country (2024-2029) & (US$ Million)

Table 131. Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2018-2023) & (US$ Million)

Table 132. Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2024-2029) & (US$ Million)

Table 133. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 134. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2018-2023) & (US$ Million)

Table 135. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2024-2029) & (US$ Million)

Table 136. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Share by Region (2018-2023)

Table 137. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Share by Region (2024-2029)

Table 138. Latin America Treatment and Prevention of Herpes Labialis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 139. Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2018-2023) & (US$ Million)

Table 140. Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2024-2029) & (US$ Million)

Table 141. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 142. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2018-2023) & (US$ Million)

Table 143. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2024-2029) & (US$ Million)

Table 144. Treatment and Prevention of Herpes Labialis Market Trends

Table 145. Treatment and Prevention of Herpes Labialis Market Drivers

Table 146. Treatment and Prevention of Herpes Labialis Market Challenges

Table 147. Treatment and Prevention of Herpes Labialis Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Treatment and Prevention of Herpes Labialis Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Treatment and Prevention of Herpes Labialis Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Treatment and Prevention of Herpes Labialis Market Share by Regions: 2022 VS 2029

Figure 4. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Treatment and Prevention of Herpes Labialis Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Treatment and Prevention of Herpes Labialis Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Treatment and Prevention of Herpes Labialis Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Valacyclovir

Figure 11. Global Valacyclovir Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Aciclovir

Figure 13. Global Aciclovir Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Famciclovir

Figure 15. Global Famciclovir Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Docosanol

Figure 17. Global Docosanol Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Product Picture of Other

Figure 19. Global Other Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 20. Global Treatment and Prevention of Herpes Labialis Market Size Share by Type: 2022 & 2029

Figure 21. North America Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2018-2029)

Figure 22. Europe Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2018-2029)

Figure 23. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2018-2029)

Figure 24. Latin America Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2018-2029)

Figure 25. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2018-2029)

Figure 26. External Use Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 27. Oral Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 28. Injection Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 29. Global Treatment and Prevention of Herpes Labialis Market Size Share by Application: 2022 & 2029

Figure 30. North America Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2018-2029)

Figure 31. Europe Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2018-2029)

Figure 32. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2018-2029)

Figure 33. Latin America Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2018-2029)

Figure 34. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2018-2029)

Figure 35. Treatment and Prevention of Herpes Labialis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 36. Global Top 5 and Top 10 Players Treatment and Prevention of Herpes Labialis Market Share in 2022

Figure 37. North America Treatment and Prevention of Herpes Labialis Market Share by Country (2018-2029)

Figure 38. U.S. Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 39. Canada Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 40. Germany Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 41. France Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 42. U.K. Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 43. Italy Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 44. Russia Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 45. Nordic Countries Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 46. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Share by Region (2018-2029)

Figure 47. China Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 48. Japan Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 49. South Korea Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 50. Southeast Asia Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 51. India Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 52. Australia Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 53. Latin America Treatment and Prevention of Herpes Labialis Market Share by Country (2018-2029)

Figure 54. Mexico Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 55. Brazil Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 56. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Share by Country (2018-2029)

Figure 57. Turkey Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 58. Saudi Arabia Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 59. UAE Treatment and Prevention of Herpes Labialis Market Size (2018-2029) & (US$ Million)

Figure 60. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Antiviral Nanocoatings Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39D11431

Mon May 06 00:00:00 UTC 2024

Add to Cart

Global Inhaled Nasal Influenza Vaccine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24O9093

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Needle-Free Influenza Vaccine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6Z9583

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Chronic Cough Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21Y10065

Sun Apr 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions